Real-world outcomes of ponatinib treatment in 724 patients with CML and Ph+ ALL: a post-marketing surveillance study with a special interest in arterial occlusive events in Japan.

Autor: Takahashi, Naoto, Kondo, Takeshi, Ikari, Yuji, Fukumoto, Yoshihiro, Hatake, Kiyohiko, Masunari, Akira, Nishibayashi, Seiji, Kageyama, Akiko, Fukuta, Yasuhiko, Tojo, Arinobu
Zdroj: Japanese Journal of Clinical Oncology; Aug2024, Vol. 54 Issue 8, p930-938, 9p
Databáze: Complementary Index